Questions posed to drug-information services concerning the treatment of attention-deficit/hyperactivity
disorder (ADHD) are not uncommon.
1
At our drug-information service in Norway, we recently received a pertinent question,
from a senior consultant from a district psychiatric center, about the optimal number
of treatment trials in adult patients with ADHD: “We experience a lot of trial and
error which occupies the physician's resources. I am unsure about the utility value
for us, and more importantly for the patients. My question for you is, if there is
any rationale for trying a fourth or fifth treatment trial when the previous attempts
have failed?”.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Review of questions concerning clinical drug interactions in ADHD treatment from physicians in Norway.Front Pharmacol. 2020; 11607915
- A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD).Front Hum Neurosci. 2019; 11: 42
- Adult ADHD and comorbid disorders: clinical implications of a dimensional approach.BMC Psychiatry. 2017; 17: 302
- Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.J Manag Care Spec Pharm. 2022; 28: 168-179
- Patient-centred prescribing.Australian Prescriber. 2013; 36: 199-201
Attention Deficit Hyperactivity Disorder: Diagnosis and Management [NICE website]. Available at: www.nice.org.uk/guidance/ng87. Accessed February 22, 2022.
- Second opinions in psychiatry: a review.J Psychiatr Pract. 2018; 24: 434-442
- Benefits of a national network of drug information centres: RELIS.Eur J Clin Pharmacol. 2017; 73: 125-126
Aiken C. How to Switch Stimulants: A Dosing Guide for ADHD [Psychiat Times online]. Available at: https://www.psychiatrictimes.com/view/how-to-switch-stimulants-dosing-guide-for-adhd. Accessed February 22, 2022.
Dodson W. 11 Steps to Prescribing and Using ADHD Medication Effectively [Attitude Magazine online]. Available at: https://www.additudemag.com/adhd-medication-11-steps-for-prescribing-it-effectively. Accessed February 22, 2022.
Article info
Publication history
Published online: April 29, 2022
Accepted:
April 7,
2022
Identification
Copyright
© 2022 Elsevier Inc.
